Roche says hemophilia drug Hemlibra wins EU approval

ZURICH (Reuters) - Swiss group Roche said on Tuesday the European Commission has approved its drug Hemlibra for people with hemophilia A who have developed resistance to standard treatments.

from Reuters: Health News http://ift.tt/2ovX15z
via IFTTT